ClinicalTrials.gov record

Completed Early Phase 1 Interventional Accepts healthy volunteers Results available

Cardiovascular Disease Risk in Women With Endometriosis

ClinicalTrials.gov ID: NCT03746535

Public ClinicalTrials.gov record NCT03746535. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 26, 2026, 3:48 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Mechanisms and Interventions Addressing Accelerated Cardiovascular Disease Risk in Women With Endometriosis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To test the hypothesis that estrogen suppression impairs endothelial dysfunction in endometriosis.

Study identification

NCT ID: NCT03746535
Recruitment status: Completed
Study type: Interventional
Phase: Early Phase 1
Lead sponsor: Yale University; Other
Enrollment: 21 participants

Conditions and interventions

Conditions

Endometriosis

Interventions

Elagolix Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 45 Years
Sex: Female
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jul 1, 2022 (Actual)
Primary completion: May 27, 2025 (Actual)
Completion: May 27, 2025 (Actual)
Last update posted: Oct 16, 2026

2022 – 2025

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Yale School of Medicine	New Haven	Connecticut	06519	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT03746535, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Oct 16, 2026 · Synced Oct 26, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03746535 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →